Arizona Oncology Associates

Phoenix, Arizona 85016

0 studies enrolling now · 11 studies all time

What they study most

Breast Cancer, Cervical Cancer, Chronic Myelogenous Leukemia - Chronic Phase, Epithelial Ovarian Cancer, Fallopian Tube Cancer, Metastatic Breast Cancer, Non Small Cell Lung Cancer (NSCLC), Ovarian Cancer, Peritoneal Cancer, Platinum-resistant Ovarian Cancer, Recurrent or Metastatic, Platinum-refractory Cervical Cancer, Soft Tissue Sarcoma

Studies at this site

• Safety and Efficacy of Tisotumab Vedotin Monotherapy & in Combination With Other Cancer Agents in Subjects With Cervical Cancer — Stopped early
• Alpelisib Plus Olaparib in Platinum-resistant/Refractory, High-grade Serous Ovarian Cancer, With no Germline BRCA Mutation Detected — Stopped early
• A Study of Tiragolumab Plus Atezolizumab and Atezolizumab Monotherapy in Participants With Metastatic and/or Recurrent PD-L1-Positive Cervical Cancer — Completed
• Asciminib in Monotherapy for Chronic Myeloid Leukemia in Chronic Phase (CML-CP) With and Without T315I Mutation — Completed
• Study With Afuresertib and Paclitaxel in Platinum Resistant Ovarian — Completed
• Study of Cemiplimab in Adults With Cervical Cancer — Completed
• A Study of Mirvetuximab Soravtansine in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression — Completed
• Study to Assess the Safety and Efficacy of Ribociclib (LEE011) in Combination With Letrozole for the Treatment of Men and Pre/Postmenopausal Women With HR+ HER2- aBC — Completed
• A Safety Trial of Nivolumab in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Progressed During or After Receiving At Least One Prior Chemotherapy Regimen — Completed
• Characterization of Circulating Tumor Cells (CTC) From Patients With Metastatic Breast Cancer Using the CTC-Endocrine Therapy Index — Completed
• Study of Palifosfamide-tris in Combination With Doxorubicin in Patients With Front-line Metastatic Soft Tissue Sarcoma — Completed